Meyer Handelman CO Abbott Laboratories Transaction History

Meyer Handelman CO

$2.83 Billion
Q2 2024

A detailed history of Meyer Handelman CO transactions in Abbott Laboratories stock. As of the latest transaction made, Meyer Handelman CO holds 108,033 shares of ABT stock, worth $12.1 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

108,033

Previous 108,533 0.46%

Holding current value

$12.1 Million

Previous $12.3 Million 9.0%

% of portfolio

0.4%

Previous 0.43%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $50,365 - $56,220	-500 Reduced 0.46%	108,033 $11.2 Million
Q2 2023 Jul 21, 2023	BUY	$100.78 - $112.29 $151,170 - $168,435	1,500 Added 1.4%	108,533 $11.8 Million
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $208,751 - $244,897	2,196 Added 2.09%	107,033 $11.8 Million
Q4 2021 Jan 25, 2022	SELL	$115.53 - $141.46 $243,306 - $297,914	-2,106 Reduced 1.97%	104,837 $14.8 Million
Q2 2021 Aug 18, 2021	BUY	$105.79 - $124.53 $84,632 - $99,624	800 Added 0.75%	106,943 $12.4 Million
Q1 2021 May 03, 2021	BUY	$108.84 - $128.23 $261,216 - $307,752	2,400 Added 2.31%	106,143 $12.7 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $882,000 - $961,128	8,400 Added 8.81%	103,743 $11.4 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $229,100 - $278,225	-2,500 Reduced 2.56%	95,343 $10.4 Million
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $15,313 - $19,600	-200 Reduced 0.2%	97,843 $8.95 Million
Q1 2020 Apr 22, 2020	SELL	$62.82 - $91.86 $125 - $183	-2 Reduced -0.0%	98,043 $7.74 Million
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $47,106 - $52,440	-600 Reduced 0.61%	98,045 $8.52 Million
Q3 2019 Oct 07, 2019	SELL	$81.84 - $88.74 $32,736 - $35,496	-400 Reduced 0.4%	98,645 $8.25 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $109,320 - $127,500	-1,500 Reduced 1.49%	99,045 $8.33 Million
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $6,622 - $8,006	-100 Reduced 0.1%	100,545 $7.82 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $205,858 - $233,207	-3,140 Reduced 3.03%	100,645 $7.28 Million
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $60,810 - $73,360	-1,000 Reduced 0.95%	103,785 $7.61 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $230,280 - $254,160	4,000 Added 3.97%	104,785 $6.39 Million
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $24,907 - $26,666	464 Added 0.46%	100,785 $5.75 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $4.82 Million - $5.38 Million	100,321	100,321 $5.35 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Abbott Laboratories Transaction History